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Letter to the Editor 
Modifications to the HEALing Communities Study in response to COVID-19 related disruptions 
The COVID-19 pandemic has coincided with a rise in opioid-related 
overdose deaths and placed significant burdens on medical, substance 
use and mental health treatment systems that might otherwise imple-
ment evidence-based practices (EBPs) to reduce these deaths (Centers 
for Disease Control and Prevention, 2020). These COVID-19 related 
disruptions significantly impacted the implementation of the Commu-
nities That HEAL (CTH) Intervention. As a consequence, the study 
leadership and federal sponsors agreed to modify the design of the 
HEALing Communities Study (HCS; The HEALing Communities Study 
Consortium, 2020) in January 2021. While the study design, hypothe-
ses, measurement, and primary and secondary outcomes remain un-
changed, the study end date will be extended by 12 months (ending 
3/31/24) as follows:  
• The implementation period for Wave 1 communities will be 
extended by 6 months (ending 6/30/22), and the implementation 
period for Wave 2 communities will be delayed by 6 months (7/1/ 
22− 6/30/23). 
• The comparison period for testing the main and secondary hypoth-
eses between Wave 1 and Wave 2 communities will be 7/1/21− 6/ 
30/22.  
• The community engagement intervention (Sprague Martinez et al., 
2020) remains unchanged except that the implementation phases 
(Phases 5 and 6) will be extended by 6 months in Wave 1 commu-
nities. Many of the advisory and coalition meetings have been con-
verted to video format (e.g., Zoom).  
• The menu of EBPs outlined in the ORCCA (Winhusen et al., 2020) 
remains unchanged except that the strategies will be delivered for an 
additional 6 months in Wave 1 communities. Coalitions have 
emphasized strategies that can be delivered using telehealth.  
• The communication campaigns (Lefebvre et al., 2020) in Wave 1 
communities will be reduced to 4 unique campaigns (i.e., stigma, 
naloxone, MOUD initiation, MOUD retention) with the option to 
re-run any of the previous four for a 5th campaign. We anticipate 
Wave 2 communities will select and tailor 2 campaigns. 
• The implementation science (Knudsen et al., 2020) and health eco-
nomics (Aldridge et al., 2020) components will remain largely 
unchanged.  
• With the exception of aligning follow-up measures to correspond 
with new time periods, the approach to data collection and analysis 
for the main and secondary hypotheses (Slavova et al., 2020) re-
mains unchanged. 
These modifications will allow additional time and resources to 
mitigate the impact of the COVID-19 pandemic on the implementation 
of the CTH intervention. The extension also allows us to preserve the full 
12-month intervention for Wave 2 communities, as per the original 
commitment. HCS remains committed to reducing opioid overdose 
deaths by 40 % and creating a model for addressing the national opioid 
crisis. 
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